Study to compare the treatment of antifungal alone and antifungal with probiotics in vulvovaginal candidiasis
Not Applicable
- Conditions
- Health Condition 1: N768- Other specified inflammation of vagina and vulva
- Registration Number
- CTRI/2021/02/031155
- Lead Sponsor
- ady Hardinge Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All females aged 18-50 years diagnosed with vulvovaginal candidiasis.
Diagnosis of VVC will be confirmed by the presence of clinical symptoms and signs, and a positive microscopic examination or positive vaginal culture or both.
Exclusion Criteria
Pregnant and lactating females.
Recurrent vulvovaginal candidiasis (4 or more episodes of symptomatic vulvovaginal
candidiasis within 1 year)
Vaginal discharge other than those of candidiasis or mixed infection
Taking any kind of treatment for vulvovaginal candidiasis/ probiotics within last one
month.
Other pathologies (immunodeficiency, diabetes)
Patient not willing for sexual abstinence/barrier protection during the study period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method